http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 02 Sep 2026 06:05:19 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/New+Coverage/Lucid+Capital+Markets+Starts+Xtant+Medical+%28XTNT%29+at+Buy/27015146.html <p>Lucid Capital Markets analyst Alex Nowak initiates coverage on Xtant Medical (NYSE: XTNT) with a Buy rating and a price target of $1.00.</p><p>The analyst comments "Pure-Play Biologics Supplier & Contract Manufacturer: Xtant is an orthobiologics manufacturing company capable of producing all five categories in-house: demineralized bone matrix (DBM), allograft, cellular allograft, synthetic bone graft, and growth factor, and its portfolio and capabilities address three-fourths of the U.S. orthobiologics market. Competitors specialize and outsource the rest, whereas Xtant owns the entire shelf with manufacturing capacity. This simplifies hospital national-account contracting when Xtantreps sell the product, the portfolio fits into multiple third-party http://www.streetinsider.com/New+Coverage/Lucid+Capital+Markets+Starts+Xtant+Medical+%28XTNT%29+at+Buy/27015146.html Wed, 02 Sep 2026 06:05:19 -0400 XTNT http://www.streetinsider.com/Analyst+Comments/Lucid+Capital+Markets+Starts+Xtant+Medical+%28XTNT%29+at+Buy/27015146.html <p>Lucid Capital Markets analyst Alex Nowak initiates coverage on Xtant Medical (NYSE: XTNT) with a Buy rating and a price target of $1.00.</p><p>The analyst comments "Pure-Play Biologics Supplier & Contract Manufacturer: Xtant is an orthobiologics manufacturing company capable of producing all five categories in-house: demineralized bone matrix (DBM), allograft, cellular allograft, synthetic bone graft, and growth factor, and its portfolio and capabilities address three-fourths of the U.S. orthobiologics market. Competitors specialize and outsource the rest, whereas Xtant owns the entire shelf with manufacturing capacity. This simplifies hospital national-account contracting when Xtantreps sell the product, the portfolio fits into multiple third-party http://www.streetinsider.com/Analyst+Comments/Lucid+Capital+Markets+Starts+Xtant+Medical+%28XTNT%29+at+Buy/27015146.html Wed, 02 Sep 2026 06:05:19 -0400 XTNT http://www.streetinsider.com/Hot+Comments/Lucid+Capital+Markets+Starts+Xtant+Medical+%28XTNT%29+at+Buy/27015146.html <p>Lucid Capital Markets analyst Alex Nowak initiates coverage on Xtant Medical (NYSE: XTNT) with a Buy rating and a price target of $1.00.</p><p>The analyst comments "Pure-Play Biologics Supplier & Contract Manufacturer: Xtant is an orthobiologics manufacturing company capable of producing all five categories in-house: demineralized bone matrix (DBM), allograft, cellular allograft, synthetic bone graft, and growth factor, and its portfolio and capabilities address three-fourths of the U.S. orthobiologics market. Competitors specialize and outsource the rest, whereas Xtant owns the entire shelf with manufacturing capacity. This simplifies hospital national-account contracting when Xtantreps sell the product, the portfolio fits into multiple third-party http://www.streetinsider.com/Hot+Comments/Lucid+Capital+Markets+Starts+Xtant+Medical+%28XTNT%29+at+Buy/27015146.html Wed, 02 Sep 2026 06:05:19 -0400 XTNT http://www.streetinsider.com/Hot+New+Coverage/Lucid+Capital+Markets+Starts+Xtant+Medical+%28XTNT%29+at+Buy/27015146.html <p>Lucid Capital Markets analyst Alex Nowak initiates coverage on Xtant Medical (NYSE: XTNT) with a Buy rating and a price target of $1.00.</p><p>The analyst comments "Pure-Play Biologics Supplier & Contract Manufacturer: Xtant is an orthobiologics manufacturing company capable of producing all five categories in-house: demineralized bone matrix (DBM), allograft, cellular allograft, synthetic bone graft, and growth factor, and its portfolio and capabilities address three-fourths of the U.S. orthobiologics market. Competitors specialize and outsource the rest, whereas Xtant owns the entire shelf with manufacturing capacity. This simplifies hospital national-account contracting when Xtantreps sell the product, the portfolio fits into multiple third-party http://www.streetinsider.com/Hot+New+Coverage/Lucid+Capital+Markets+Starts+Xtant+Medical+%28XTNT%29+at+Buy/27015146.html Wed, 02 Sep 2026 06:05:19 -0400 XTNT http://www.streetinsider.com/Corporate+News/Xtant+Medical+and+BioHorizons+form+dental+distribution+deal/26985085.html <p>Xtant Medical Holdings, Inc. (NYSE American: XTNT) has entered into an exclusive distribution partnership with BioHorizons, a subsidiary of Henry Schein, Inc., to sell Xtant's allogeneic growth factor technology in the dental and oral-maxillofacial procedure markets.</p><p>Under the agreement, BioHorizons will distribute the product under the private brand name Prolifica™ through its commercial network in the United States and Canada. The product is based on Xtant's OsteoFactor Pro™ technology and is described as a blend of allogeneic growth factors stabilized by native human collagen, designed to support bone healing and regeneration.</p><p>Sean Browne, President and CEO of Xtant Medical, said, "This exclusive http://www.streetinsider.com/Corporate+News/Xtant+Medical+and+BioHorizons+form+dental+distribution+deal/26985085.html Thu, 27 Aug 2026 08:01:13 -0400 XTNT http://www.streetinsider.com/Press+Releases/Xtant+Medical+Announces+Exclusive+Partnership+with+BioHorizons+to+Expand+Access+to+Xtant%27s+Allogeneic+Growth+Factor+into+the+Dental+Market/26985011.html <div class="xn-content"> <p class="prntac"><i>Partnership leverages BioHorizons' commercial network to broaden availability of Xtant's allogeneic growth factor technology, OsteoFactor Pro™, which BioHorizons will private brand as Prolifica™</i></p><p><span class="legendSpanClass"><location value="LU/us.mt.belgrd" idsrc="xmltag.org" >BELGRADE, Mont.</location></span>, <span class="legendSpanClass"><chron>Aug. 27, 2026</chron></span> /PRNewswire/ -- <span value="AMEX:XTNT" idsrc="xmltag.org" >Xtant Medical Holdings, Inc.</span> (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and wound care disorders, announced an exclusive partnership with BioHorizons (a <span value="ACORN:5021092370" idsrc="xmltag.org" >Henry Schein</span>, Inc. company), whereby BioHorizons will distribute Xtant's allogeneic growth factor technology under the private brand <b>Prolifica™</b> through its commercial network.</p> <div http://www.streetinsider.com/Press+Releases/Xtant+Medical+Announces+Exclusive+Partnership+with+BioHorizons+to+Expand+Access+to+Xtant%27s+Allogeneic+Growth+Factor+into+the+Dental+Market/26985011.html Thu, 27 Aug 2026 08:00:00 -0400 A.50210923 O.00832288 O.07329216 XTNT http://www.streetinsider.com/Press+Releases/Xtant+Medical+Announces+Exclusive+Partnership+with+BioHorizons+to+Expand+Access+to+Xtant%27s+Allogeneic+Growth+Factor+into+the+Dental+Market/26985011.html <div class="xn-content"> <p class="prntac"><i>Partnership leverages BioHorizons' commercial network to broaden availability of Xtant's allogeneic growth factor technology, OsteoFactor Pro™, which BioHorizons will private brand as Prolifica™</i></p><p><span class="legendSpanClass"><location value="LU/us.mt.belgrd" idsrc="xmltag.org" >BELGRADE, Mont.</location></span>, <span class="legendSpanClass"><chron>Aug. 27, 2026</chron></span> /PRNewswire/ -- <span value="AMEX:XTNT" idsrc="xmltag.org" >Xtant Medical Holdings, Inc.</span> (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and wound care disorders, announced an exclusive partnership with BioHorizons (a <span value="ACORN:5021092370" idsrc="xmltag.org" >Henry Schein</span>, Inc. company), whereby BioHorizons will distribute Xtant's allogeneic growth factor technology under the private brand <b>Prolifica™</b> through its commercial network.</p> <div http://www.streetinsider.com/Press+Releases/Xtant+Medical+Announces+Exclusive+Partnership+with+BioHorizons+to+Expand+Access+to+Xtant%27s+Allogeneic+Growth+Factor+into+the+Dental+Market/26985011.html Thu, 27 Aug 2026 08:00:00 -0400 A.50210923 O.00832288 O.07329216 XTNT http://www.streetinsider.com/Press+Releases/Xtant+Medical+Announces+Exclusive+Partnership+with+BioHorizons+to+Expand+Access+to+Xtant%27s+Allogeneic+Growth+Factor+into+the+Dental+Market/26985011.html <div class="xn-content"> <p class="prntac"><i>Partnership leverages BioHorizons' commercial network to broaden availability of Xtant's allogeneic growth factor technology, OsteoFactor Pro™, which BioHorizons will private brand as Prolifica™</i></p><p><span class="legendSpanClass"><location value="LU/us.mt.belgrd" idsrc="xmltag.org" >BELGRADE, Mont.</location></span>, <span class="legendSpanClass"><chron>Aug. 27, 2026</chron></span> /PRNewswire/ -- <span value="AMEX:XTNT" idsrc="xmltag.org" >Xtant Medical Holdings, Inc.</span> (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and wound care disorders, announced an exclusive partnership with BioHorizons (a <span value="ACORN:5021092370" idsrc="xmltag.org" >Henry Schein</span>, Inc. company), whereby BioHorizons will distribute Xtant's allogeneic growth factor technology under the private brand <b>Prolifica™</b> through its commercial network.</p> <div http://www.streetinsider.com/Press+Releases/Xtant+Medical+Announces+Exclusive+Partnership+with+BioHorizons+to+Expand+Access+to+Xtant%27s+Allogeneic+Growth+Factor+into+the+Dental+Market/26985011.html Thu, 27 Aug 2026 08:00:00 -0400 A.50210923 O.00832288 O.07329216 XTNT http://www.streetinsider.com/Press+Releases/Xtant+Medical+Announces+Exclusive+Partnership+with+BioHorizons+to+Expand+Access+to+Xtant%27s+Allogeneic+Growth+Factor+into+the+Dental+Market/26985011.html <div class="xn-content"> <p class="prntac"><i>Partnership leverages BioHorizons' commercial network to broaden availability of Xtant's allogeneic growth factor technology, OsteoFactor Pro™, which BioHorizons will private brand as Prolifica™</i></p><p><span class="legendSpanClass"><location value="LU/us.mt.belgrd" idsrc="xmltag.org" >BELGRADE, Mont.</location></span>, <span class="legendSpanClass"><chron>Aug. 27, 2026</chron></span> /PRNewswire/ -- <span value="AMEX:XTNT" idsrc="xmltag.org" >Xtant Medical Holdings, Inc.</span> (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and wound care disorders, announced an exclusive partnership with BioHorizons (a <span value="ACORN:5021092370" idsrc="xmltag.org" >Henry Schein</span>, Inc. company), whereby BioHorizons will distribute Xtant's allogeneic growth factor technology under the private brand <b>Prolifica™</b> through its commercial network.</p> <div http://www.streetinsider.com/Press+Releases/Xtant+Medical+Announces+Exclusive+Partnership+with+BioHorizons+to+Expand+Access+to+Xtant%27s+Allogeneic+Growth+Factor+into+the+Dental+Market/26985011.html Thu, 27 Aug 2026 08:00:00 -0400 A.50210923 O.00832288 O.07329216 XTNT http://www.streetinsider.com/PRNewswire/Xtant+Medical+Announces+Exclusive+Partnership+with+BioHorizons+to+Expand+Access+to+Xtant%27s+Allogeneic+Growth+Factor+into+the+Dental+Market/26985011.html <div class="xn-content"> <p class="prntac"><i>Partnership leverages BioHorizons' commercial network to broaden availability of Xtant's allogeneic growth factor technology, OsteoFactor Pro™, which BioHorizons will private brand as Prolifica™</i></p><p><span class="legendSpanClass"><location value="LU/us.mt.belgrd" idsrc="xmltag.org" >BELGRADE, Mont.</location></span>, <span class="legendSpanClass"><chron>Aug. 27, 2026</chron></span> /PRNewswire/ -- <span value="AMEX:XTNT" idsrc="xmltag.org" >Xtant Medical Holdings, Inc.</span> (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and wound care disorders, announced an exclusive partnership with BioHorizons (a <span value="ACORN:5021092370" idsrc="xmltag.org" >Henry Schein</span>, Inc. company), whereby BioHorizons will distribute Xtant's allogeneic growth factor technology under the private brand <b>Prolifica™</b> through its commercial network.</p> <div http://www.streetinsider.com/PRNewswire/Xtant+Medical+Announces+Exclusive+Partnership+with+BioHorizons+to+Expand+Access+to+Xtant%27s+Allogeneic+Growth+Factor+into+the+Dental+Market/26985011.html Thu, 27 Aug 2026 08:00:00 -0400 A.50210923 O.00832288 O.07329216 XTNT http://www.streetinsider.com/PRNewswire/Xtant+Medical+Announces+Exclusive+Partnership+with+BioHorizons+to+Expand+Access+to+Xtant%27s+Allogeneic+Growth+Factor+into+the+Dental+Market/26985011.html <div class="xn-content"> <p class="prntac"><i>Partnership leverages BioHorizons' commercial network to broaden availability of Xtant's allogeneic growth factor technology, OsteoFactor Pro™, which BioHorizons will private brand as Prolifica™</i></p><p><span class="legendSpanClass"><location value="LU/us.mt.belgrd" idsrc="xmltag.org" >BELGRADE, Mont.</location></span>, <span class="legendSpanClass"><chron>Aug. 27, 2026</chron></span> /PRNewswire/ -- <span value="AMEX:XTNT" idsrc="xmltag.org" >Xtant Medical Holdings, Inc.</span> (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and wound care disorders, announced an exclusive partnership with BioHorizons (a <span value="ACORN:5021092370" idsrc="xmltag.org" >Henry Schein</span>, Inc. company), whereby BioHorizons will distribute Xtant's allogeneic growth factor technology under the private brand <b>Prolifica™</b> through its commercial network.</p> <div http://www.streetinsider.com/PRNewswire/Xtant+Medical+Announces+Exclusive+Partnership+with+BioHorizons+to+Expand+Access+to+Xtant%27s+Allogeneic+Growth+Factor+into+the+Dental+Market/26985011.html Thu, 27 Aug 2026 08:00:00 -0400 A.50210923 O.00832288 O.07329216 XTNT http://www.streetinsider.com/PRNewswire/Xtant+Medical+Announces+Exclusive+Partnership+with+BioHorizons+to+Expand+Access+to+Xtant%27s+Allogeneic+Growth+Factor+into+the+Dental+Market/26985011.html <div class="xn-content"> <p class="prntac"><i>Partnership leverages BioHorizons' commercial network to broaden availability of Xtant's allogeneic growth factor technology, OsteoFactor Pro™, which BioHorizons will private brand as Prolifica™</i></p><p><span class="legendSpanClass"><location value="LU/us.mt.belgrd" idsrc="xmltag.org" >BELGRADE, Mont.</location></span>, <span class="legendSpanClass"><chron>Aug. 27, 2026</chron></span> /PRNewswire/ -- <span value="AMEX:XTNT" idsrc="xmltag.org" >Xtant Medical Holdings, Inc.</span> (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and wound care disorders, announced an exclusive partnership with BioHorizons (a <span value="ACORN:5021092370" idsrc="xmltag.org" >Henry Schein</span>, Inc. company), whereby BioHorizons will distribute Xtant's allogeneic growth factor technology under the private brand <b>Prolifica™</b> through its commercial network.</p> <div http://www.streetinsider.com/PRNewswire/Xtant+Medical+Announces+Exclusive+Partnership+with+BioHorizons+to+Expand+Access+to+Xtant%27s+Allogeneic+Growth+Factor+into+the+Dental+Market/26985011.html Thu, 27 Aug 2026 08:00:00 -0400 A.50210923 O.00832288 O.07329216 XTNT http://www.streetinsider.com/PRNewswire/Xtant+Medical+Announces+Exclusive+Partnership+with+BioHorizons+to+Expand+Access+to+Xtant%27s+Allogeneic+Growth+Factor+into+the+Dental+Market/26985011.html <div class="xn-content"> <p class="prntac"><i>Partnership leverages BioHorizons' commercial network to broaden availability of Xtant's allogeneic growth factor technology, OsteoFactor Pro™, which BioHorizons will private brand as Prolifica™</i></p><p><span class="legendSpanClass"><location value="LU/us.mt.belgrd" idsrc="xmltag.org" >BELGRADE, Mont.</location></span>, <span class="legendSpanClass"><chron>Aug. 27, 2026</chron></span> /PRNewswire/ -- <span value="AMEX:XTNT" idsrc="xmltag.org" >Xtant Medical Holdings, Inc.</span> (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and wound care disorders, announced an exclusive partnership with BioHorizons (a <span value="ACORN:5021092370" idsrc="xmltag.org" >Henry Schein</span>, Inc. company), whereby BioHorizons will distribute Xtant's allogeneic growth factor technology under the private brand <b>Prolifica™</b> through its commercial network.</p> <div http://www.streetinsider.com/PRNewswire/Xtant+Medical+Announces+Exclusive+Partnership+with+BioHorizons+to+Expand+Access+to+Xtant%27s+Allogeneic+Growth+Factor+into+the+Dental+Market/26985011.html Thu, 27 Aug 2026 08:00:00 -0400 A.50210923 O.00832288 O.07329216 XTNT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Xtant+Medical+Holdings%2C+++For%3A+Aug+15++Filed+by%3A+Lipschultz+Tyler/26945826.html si-local-file:///var/storage/secattach/20260818/26945826.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Xtant+Medical+Holdings%2C+++For%3A+Aug+15++Filed+by%3A+Lipschultz+Tyler/26945826.html Tue, 18 Aug 2026 18:35:00 -0400 O.07329216 XTNT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Xtant+Medical+Holdings%2C+++For%3A+Aug+15++Filed+by%3A+Lipschultz+Tyler/26945826.html si-local-file:///var/storage/secattach/20260818/26945826.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Xtant+Medical+Holdings%2C+++For%3A+Aug+15++Filed+by%3A+Lipschultz+Tyler/26945826.html Tue, 18 Aug 2026 18:35:00 -0400 O.07329216 XTNT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Xtant+Medical+Holdings%2C+++For%3A+Aug+15++Filed+by%3A+BAKEWELL+JOHN+K/26945797.html si-local-file:///var/storage/secattach/20260818/26945797.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Xtant+Medical+Holdings%2C+++For%3A+Aug+15++Filed+by%3A+BAKEWELL+JOHN+K/26945797.html Tue, 18 Aug 2026 18:28:00 -0400 O.07329216 XTNT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Xtant+Medical+Holdings%2C+++For%3A+Aug+15++Filed+by%3A+BAKEWELL+JOHN+K/26945797.html si-local-file:///var/storage/secattach/20260818/26945797.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Xtant+Medical+Holdings%2C+++For%3A+Aug+15++Filed+by%3A+BAKEWELL+JOHN+K/26945797.html Tue, 18 Aug 2026 18:28:00 -0400 O.07329216 XTNT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Xtant+Medical+Holdings%2C+++For%3A+Aug+15++Filed+by%3A+Beeson+Jonn+R./26945780.html si-local-file:///var/storage/secattach/20260818/26945780.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Xtant+Medical+Holdings%2C+++For%3A+Aug+15++Filed+by%3A+Beeson+Jonn+R./26945780.html Tue, 18 Aug 2026 18:22:00 -0400 O.07329216 XTNT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Xtant+Medical+Holdings%2C+++For%3A+Aug+15++Filed+by%3A+Beeson+Jonn+R./26945780.html si-local-file:///var/storage/secattach/20260818/26945780.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Xtant+Medical+Holdings%2C+++For%3A+Aug+15++Filed+by%3A+Beeson+Jonn+R./26945780.html Tue, 18 Aug 2026 18:22:00 -0400 O.07329216 XTNT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Xtant+Medical+Holdings%2C+++For%3A+Aug+15++Filed+by%3A+JAIN+ABHINAV/26945752.html si-local-file:///var/storage/secattach/20260818/26945752.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Xtant+Medical+Holdings%2C+++For%3A+Aug+15++Filed+by%3A+JAIN+ABHINAV/26945752.html Tue, 18 Aug 2026 18:15:00 -0400 O.07329216 XTNT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Xtant+Medical+Holdings%2C+++For%3A+Aug+15++Filed+by%3A+JAIN+ABHINAV/26945752.html si-local-file:///var/storage/secattach/20260818/26945752.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Xtant+Medical+Holdings%2C+++For%3A+Aug+15++Filed+by%3A+JAIN+ABHINAV/26945752.html Tue, 18 Aug 2026 18:15:00 -0400 O.07329216 XTNT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Xtant+Medical+Holdings%2C+++For%3A+Aug+15++Filed+by%3A+Vizirgianakis+Stavros+G./26945721.html si-local-file:///var/storage/secattach/20260818/26945721.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Xtant+Medical+Holdings%2C+++For%3A+Aug+15++Filed+by%3A+Vizirgianakis+Stavros+G./26945721.html Tue, 18 Aug 2026 18:09:00 -0400 O.07329216 XTNT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Xtant+Medical+Holdings%2C+++For%3A+Aug+15++Filed+by%3A+Vizirgianakis+Stavros+G./26945721.html si-local-file:///var/storage/secattach/20260818/26945721.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Xtant+Medical+Holdings%2C+++For%3A+Aug+15++Filed+by%3A+Vizirgianakis+Stavros+G./26945721.html Tue, 18 Aug 2026 18:09:00 -0400 O.07329216 XTNT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Xtant+Medical+Holdings%2C+++For%3A+Aug+15++Filed+by%3A+Schallenberger+Mark+A./26945708.html si-local-file:///var/storage/secattach/20260818/26945708.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Xtant+Medical+Holdings%2C+++For%3A+Aug+15++Filed+by%3A+Schallenberger+Mark+A./26945708.html Tue, 18 Aug 2026 18:03:00 -0400 O.07329216 XTNT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Xtant+Medical+Holdings%2C+++For%3A+Aug+15++Filed+by%3A+Schallenberger+Mark+A./26945708.html si-local-file:///var/storage/secattach/20260818/26945708.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Xtant+Medical+Holdings%2C+++For%3A+Aug+15++Filed+by%3A+Schallenberger+Mark+A./26945708.html Tue, 18 Aug 2026 18:03:00 -0400 O.07329216 XTNT